Subscribe to this collection to receive daily e-mail notification of new additions

Publication Year	Title	Author(s)
2013	Evaluation Of Sphingosine Kinase 1 As a Therapeutic Target In B-Lineage Acute Lymphoblastic Leukemia	Craig Wallington-Gates ; Stuart Pitson; Jason Powell; Kenneth Bradstock; Linda Bendall
Aug-2021	A phase II trial of continuous ixazomib, thalidomide and dexamethasone for relapsed and/or refractory multiple myeloma: the Australasian Myeloma Research Consortium (AMaRC) 16-02 trial	Bergin, Krystal; Yuen, Flora; Wallington-Gates, Craig ; Kalff, Anna; Sirdesai, Shreerang; Reynolds, John; Spencer, Andrew
2024	Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma	Pieter Sonneveld; Meletios A. Dimopoulos; Mario Boccadoro; Hang Quach; P. Joy Ho; Meral Beksac; Cyrille Hulin; Elisabetta Antonioli; Xavier Leleu; Silvia Mangiacavalli; Aurore Perrot; Michele Cavo; Angelo Belotti; Annemiek Broijl; Francesca Gay; Roberto Mina; Inger S. Nijhof; Niels W.C.J. Van De Donk; Eirini Katodritou; Fredrik Schjesvold; Anna Sureda Balari; Laura Rosiñol; Michel Delforge; Wilfried Roeloffzen; Tobias Silzle; Annette Vangsted; Hermann Einsele; Andrew Spencer; Roman Hajek; Artur Jurczyszyn; Sarah Lonergan; Tahamtan Ahmadi; Yanfang Liu; Jianping Wang; Diego Vieyra; Emilie M.J. Van Brummelen; Veronique Vanquickelberghe; Anna Sitthi-Amorn; Carla J. De Boer; Robin Carson; Paula Rodriguez-Otero; Joan Bladé; Philippe Moreau; PERSEUS Trial Investigators; Craig Wallington-Gates
2023	A sequential cohort study evaluating single-agent KappaMab and KappaMab combined with lenalidomide and low-dose dexamethasone in relapsed and/or refractory kappa light chain-restricted multiple myeloma (AMaRC 01-16)	Andrew Spencer; Anna Kalff; J Shortt; Hang Quach; Craig Wallington-Gates ; John Reynolds; Patricia Walker; Simon Harrison; Dunn Rosanne; Cameron Wellard
2012	Identification of Sphingosine Kinases As Therapeutic Targets in B-Lineage Acute Lymphoblastic Leukemia	Craig Wallington-Gates ; Kenneth F. Bradstock; Linda J. Bendall
2022	A PHASE I/II SINGLE ARM STUDY OF BELANTAMAB MAFODOTIN, CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA: AMARC 19-02 BELACARD STUDY	Masa Lasica; Andrew Spencer; Philip Campbell; Craig Wallington-Gates ; Nicole Wong Doo; Wojciech Janowski; Georgia McGaughan; Anish Puliyayil; Flora Yuen; Khoa Le; John Reynolds; Hang Quach
2013	Targeting sphingosine kinase 2 suppresses MYC expression and kills acute lymphoblastic leukemia cells	Craig Wallington-Gates
2021	A Randomized Study of Bortezomib, Cyclophosphamide and Dexamethasone Induction (VCD) Versus VCD and Daratumumab Induction Followed By Daratumumab Maintenance (VCDD) for the Initial Treatment of Transplant-Ineligible Patients with Multiple Myeloma (AMaRC 03-16)	Craig Wallington-Gates
2021	Prognostic and predictive biomarker developments in multiple myeloma	Craig Wallington-Gates
2023	A Phase I/II Single Arm Study of Belantamab Mafodotin, Carfilzomib and Dexamethasone in Patients with Relapsed Multiple Myeloma: Planned Interim Analysis of Safety and Efficacy. Amarc 19-02 Belacard Study	Masa Lasica; Andrew Spencer; Noemi Horvath; Wojt Janowski; Douglas Coghlan; Craig Wallington-Gates ; Philip Campbell; Choong Lai, Hock ; Georgia McCaughan; Weber, Nicholas ; Anish Puliyayil; Philip Wong; Deng Yachao; Khoa Le; John Reynolds; Hang Quach
2024	Expression of the chemokine receptor CCR1 decreases sensitivity to bortezomib in multiple myeloma cell lines	Mara N. Zeissig; Duncan R. Hewett; Krzysztof M. Mrozik; Vasilios Panagopoulos; Wallington-Gates, Craig ; Andrew Spencer; Sandra M. Dold; Monika Engelhardt; Kate Vandyke; Andrew C.W. Zannettino
2011	Sphingosine Kinase Inhibition Has Pre-Clinical Activity in Acute Lymphoblastic Leukemia,	Craig Wallington-Beddoe ; David Ho; Kenneth Francis Bradstock; Linda J. Bendall
2023	Circular RNAs drive oncogenic chromosomal translocations within the MLL recombinome in leukemia	Conn, Vanessa M.; Gabryelska, Marta; Toubia, John; Kirk, Kirsty; Gantley, Laura; Powell, Jason A.; Cildir, Gökhan; Marri, Shashikanth; Liu, Ryan; Stringer, Brett W.; Townley, Scott; Webb, Stuart T.; Lin, He; Samaraweera, Saumya E.; Bailey, Sheree; Moore, Andrew S. ; Maybury, Mellissa; Liu, Dawei; Colella, Alex D.; Chataway, Timothy; Wallington-Gates, Craig Thomas ; Walters, Lucie; Sibbons, Jane; Selth, Luke A.; Tergaonkar, Vinay; D'Andrea, Richard J.; Pitson, Stuart M.; Goodall, Gregory J.; Conn, Simon J.
12-Feb-2019	Why is optimisation of antimicrobial use difficult at the end of life?	Broom, Jennifer ; Broom, Alex; Good, Phillip; Lwin, Zarnie
Apr-2019	The impact of environmental enrichment in an acute stroke unit on how and when patients undertake activities	Rosbergen, Ingrid ; Grimley, Rohan ; Hayward, Kathryn S; Brauer, Sandra G
18-Jan-2019	Hospital organizational context and delivery of evidence-based stroke care: a cross-sectional study	Andrew, Nadine E; Middleton, Sandy; Grimley, Rohan ; Anderson, Craig S; Donnan, Geoffrey A; Lannin, Natasha A.; Stroil-Salama, Enna; Grabsch, Brenda; Kilkenny, Monique F; Squires, Janet E; Cadilhac, Dominique A
2007	Paediatric intussusception: Epidemiology and outcome	Acworth, J. P.; Perel, S. B.; Blanch, A. J. M.
2007	A professional kitesurfer with multiple liver lesions	Buchholz, S.; Rudan, G.
2007	Current management of acute coronary syndromes in Australia: observations from the acute coronary syndromes prospective audit	Amerena, J.; Brieger, D.; Coverdale, S.; Astley, C.; Chew, D. P.; Rankin, J.
2007	Maternal vitamin D deficiency associated with neonatal hypocalcaemic convulsions	Isaza, F.; Camadoo, L.; Tibbott, R.